Featured Story | By Nick Paul Taylor Pfizer’s vision for a banner 2022 in gene therapies is over. Having previously expected to post interim data on a trio of phase 3 programs next year, Pfizer has now delayed all the readouts, setting back its plans in hemophilia and Duchenne muscular dystrophy. read more |
| |
|---|
|
Top Stories By Kyle LaHucik The Cystic Fibrosis Foundation will give $20 million upfront and up to another $90 million to Flagship Pioneering-founded biotechs to work on potential new treatments. The deal is part of the foundation's $500 million pledge to find a cure for the disease that causes severe damage in the lungs. read more By Annalee Armstrong Sage Therapeutics has slightly tweaked the primary endpoint for a phase 3 trial of the Biogen-partnered depression drug zuranolone, a move analysts say is likely designed to avoid a miss on the original goal and one that could complicate the drug's real-world use. read more Sponsored by: IPM.ai Rare diseases demand a modern recruitment approach grounded in uncovering the ideal, medically-eligible patient population with the highest propensity for study enrollment and retention. read more By Nick Paul Taylor Antios Therapeutics is going full throttle in pursuit of a curative hepatitis B therapy, raising $75 million just months after its previous round to accelerate phase 2b development of its lead prospect. read more Sponsored By: Avance Clinical the Australian CRO for global biotechs Australia’s Avance Clinical: how intranasal biotechs can expedite trials with rapid approval processes - including no IND and a 43.5% incentive rebate - to tap $71 billion market read more By Annalee Armstrong PhaseBio’s Brilinta reversal drug has scored a mid-stage win without any adverse events or blood clot issues, layering on the data to support the therapy that’s already pushing through phase 3. read more By Kyle LaHucik It took 17 years to get its first FDA greenlight. Three months later, Cara Therapeutics founding CEO Derek Chalmers exits the top perch as LEO Pharma's U.S. CEO and president enters the role. read more By Ben Adams It still feels as if the use of cell therapy is a fresh innovation, but inertia is the enemy of progress, and next-gen approaches are already here. read more By Kyle LaHucik About one-third of staff at clinical trial sites in U.S. academic medical centers and community hospitals are representative of minority populations, according to a new study by Tufts University. That figure is higher, at nearly half, for personnel who work in private practices, and Europe lags behind at just 10% representation. read more By Kevin Dunleavy By a unanimous vote, CDC vaccine advisers have blessed the Pfizer-BioNTech COVID-19 vaccine with no restrictions for children ages 5 to 11, setting up the shot to be distributed in the U.S. later this week. The recommendation now moves forward to CDC Director Rochelle Walensky. read more By Conor Hale The company has launched its Pogo Automatic monitoring system following years of development, with an FDA-cleared blood glucose reader equipped with cartridges that provide up to 10 fingerstick tests with the quick push of a button. read more By Robert King Humana posted $1.5 billion in profit for the third quarter of the year thanks in part to its Medicare Advantage growth but cut its financial outlook for the rest of 2021. read more | 
| LabConnect is the leader in innovative central laboratory services for advanced therapies. Far more than typical central laboratory support, only LabConnect offers comprehensive, specialized services customizable to meet the unique needs of your complex clinical trials. Connect with us today. |
Resources Sponsored by: Medable, Inc. Find out how to improve clinical protocol adherence, and thus patient outcomes, by 15%+ with Medable’s latest White Paper. Sponsored by: Informa Pharma Intelligence and Oracle Health Sciences New market research provides valuable insight into the impact of adaptations made in clinical trials during the pandemic. Sponsored by: TransPerfect Life Sciences Every detail is important when selecting a new eCOA solution; learn more about the current eCOA landscape, best practices, and crucial considerations for successful eCOA solution deployment in this white paper. Sponsored by: Thermo Fisher Scientific Learn how to develop a high-performing supply chain for cGMP chemicals used throughout your biologics workflow. Download the free whitepaper from Thermo Fisher Scientific Sponsored by: Drexel University Online Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more. Sponsored by: Oracle Health Sciences New research indicates an accelerated adoption of decentralized clinical trials due to COVID-19. Sponsored by: Box Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization. | 
